ATE512969T1 - Benzimidazolderivate als selektive säurepumpenhemmer - Google Patents

Benzimidazolderivate als selektive säurepumpenhemmer

Info

Publication number
ATE512969T1
ATE512969T1 AT07825160T AT07825160T ATE512969T1 AT E512969 T1 ATE512969 T1 AT E512969T1 AT 07825160 T AT07825160 T AT 07825160T AT 07825160 T AT07825160 T AT 07825160T AT E512969 T1 ATE512969 T1 AT E512969T1
Authority
AT
Austria
Prior art keywords
compounds
disease
acid pump
reflux disease
pharmaceutically acceptable
Prior art date
Application number
AT07825160T
Other languages
English (en)
Inventor
Hiroki Koike
Mikio Morita
Original Assignee
Raqualia Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raqualia Pharma Inc filed Critical Raqualia Pharma Inc
Application granted granted Critical
Publication of ATE512969T1 publication Critical patent/ATE512969T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
AT07825160T 2006-09-21 2007-09-17 Benzimidazolderivate als selektive säurepumpenhemmer ATE512969T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82644206P 2006-09-21 2006-09-21
US91226407P 2007-04-17 2007-04-17
PCT/IB2007/002749 WO2008035195A1 (en) 2006-09-21 2007-09-17 Benzimidazole derivatives as selective acid pump inhibitors

Publications (1)

Publication Number Publication Date
ATE512969T1 true ATE512969T1 (de) 2011-07-15

Family

ID=38980958

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07825160T ATE512969T1 (de) 2006-09-21 2007-09-17 Benzimidazolderivate als selektive säurepumpenhemmer

Country Status (11)

Country Link
US (1) US8466166B2 (de)
EP (1) EP2081939B1 (de)
JP (1) JP5140080B2 (de)
KR (1) KR101109866B1 (de)
AT (1) ATE512969T1 (de)
BR (1) BRPI0717102A2 (de)
CA (1) CA2657550C (de)
HK (1) HK1132507A1 (de)
MX (1) MX2009000080A (de)
RU (1) RU2412188C2 (de)
WO (1) WO2008035195A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2624179A1 (en) 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
WO2008114123A1 (en) * 2007-03-21 2008-09-25 Raqualia Pharma Inc. Spiro benzimidazole derivatives as acid pump inhibitors
WO2011004882A1 (ja) * 2009-07-09 2011-01-13 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
EA021295B1 (ru) * 2012-02-29 2015-05-29 Ооо "Фармацевтическая Компания "Славянская Аптека" Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты)
EA021265B1 (ru) * 2012-02-29 2015-05-29 Ооо "Фармацевтическая Компания "Славянская Аптека" Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты)
EA022836B1 (ru) * 2012-03-02 2016-03-31 ООО "Эн.Си. ФАРМ" Фармацевтический состав для инъекций, обладающий нейропротекторной, антиамнестической, антиоксидантной, противогипоксической, противоишемической активностью (варианты)
EA020033B1 (ru) * 2012-03-11 2014-08-29 Ооо "Эн.Си.Фарм" Твердая лекарственная форма, обладающая нейропротекторной, антиамнестической, антиоксидантной, противогипоксической, противоишемической активностью (варианты)
EA020042B1 (ru) * 2012-03-11 2014-08-29 Ооо "Эн.Си.Фарм" Твердая лекарственная форма, обладающая нейропротекторной, антиамнестической, антиоксидантной, противогипоксической, противоишемической активностью (варианты)
EA020040B1 (ru) * 2012-03-11 2014-08-29 Ооо "Эн.Си.Фарм" Твердая лекарственная форма, обладающая нейропротекторной, антиамнестической, антиоксидантной, противогипоксической, противоишемической активностью (варианты)
EA021246B1 (ru) * 2012-03-14 2015-05-29 Ооо "Фармацевтическая Компания "Славянская Аптека" Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты)
EA020058B1 (ru) * 2012-03-14 2014-08-29 Ооо "Эн.Си.Фарм" Твердая лекарственная форма, обладающая нейропротекторной, антиамнестической, антиоксидантной, противогипоксической, противоишемической активностью (варианты)
BR112016011727A2 (pt) 2013-11-22 2017-08-08 CL BioSciences LLC Antagonistas de gastrina para o tratamento e prevenção de osteoporose
KR20230099093A (ko) * 2021-12-27 2023-07-04 에이치케이이노엔 주식회사 벤즈이미다졸 유도체의 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
AR043063A1 (es) 2002-12-13 2005-07-13 Altana Pharma Ag Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
US7307084B2 (en) * 2003-04-04 2007-12-11 Altana Pharma Ag Cyclic benzimidazoles
AR051041A1 (es) * 2004-10-04 2006-12-13 Altana Pharma Ag Bencimidazoles triciclicos condensados
US7449262B2 (en) * 2004-12-09 2008-11-11 Praxair Technology, Inc. Current collector to conduct an electrical current to or from an electrode layer
JP2008534476A (ja) * 2005-03-24 2008-08-28 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 胃腸疾病の治療のために有用なチオアミド置換された三環式のベンゾイミダゾール
US20080280855A1 (en) * 2005-06-22 2008-11-13 Nycomed Gmbh Process For the Production of Intermediates For the Preparation of Tricyclic Benzimidazoles

Also Published As

Publication number Publication date
KR101109866B1 (ko) 2012-04-12
RU2009114859A (ru) 2010-10-27
EP2081939A1 (de) 2009-07-29
US20100048532A1 (en) 2010-02-25
WO2008035195A1 (en) 2008-03-27
JP5140080B2 (ja) 2013-02-06
US8466166B2 (en) 2013-06-18
CA2657550C (en) 2011-11-01
HK1132507A1 (en) 2010-02-26
BRPI0717102A2 (pt) 2013-10-29
RU2412188C2 (ru) 2011-02-20
KR20090054476A (ko) 2009-05-29
CA2657550A1 (en) 2008-03-27
EP2081939B1 (de) 2011-06-15
MX2009000080A (es) 2009-01-23
JP2010504317A (ja) 2010-02-12

Similar Documents

Publication Publication Date Title
ATE512969T1 (de) Benzimidazolderivate als selektive säurepumpenhemmer
TW200732326A (en) Chromane substituted benzimidazole derivatives
ATE442140T1 (de) Chroman-substituierte benzimidazolderivate als säurepumpenantagonisten
NZ591793A (en) Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds
CL2008002834A1 (es) Compuestos heterociclicos de 5 miembros, composicion farmaceutica, util para el tratamiento de la ulcera peptidica, sindrome de zollinger-ellison, gastritis, esofagitis por reflujo, enfermedad sintomatica por reflujo gastroesofagico, esofago de barrett, cancer gastrico, hiperacidez gastrica o ulcera debido a estres posquirurgico.
NO20092464L (no) Faste former av rasemisk ilaprazol
JP2009520017A5 (de)
CY1114415T1 (el) 1-ετεροκυκλυλσουλφονυλ, 2-αμινομεθυλ, 5-(ετερο-) αρυλ υποκατεστημενα 1-η-πυρρολιου παραγωγα ως αναστολεις εκκρισης οξεος
EE04279B1 (et) Omeprasooli kristalne vorm
CL2009000547A1 (es) Forma cristalina de (r)-2[[[3-metil-4-(2,2,2-trifluoroetoxi)-2-piridinil]metil]sulfinil]-1h-bencimidazol, metodo de preparacion; composicion farmaceutica y su uso para la profilaxis o tratamiento de ulcera peptica, gastritis, esofagitis erosiva, esofago de barret,dispepsia funcional, cancer gastrico.
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
BR0211101B1 (pt) Processo melhorado para preparação de compostos tipo benzimidazol
ATE520651T1 (de) Substituierte phenylmethylbicyclocarbonsäureamidverbindungen
NO20072764L (no) Kromanderivater som er nyttige syrepumpeantagonister
SI1706383T1 (sl) Sol amina derivata karbostirila uporabna za zdravljenje, med drugim, želodčne razjede
JP2008524199A5 (de)
WO2007026218A3 (en) Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists
WO2007072142A3 (en) Benzimidazole-5-carboxamide derivatives
UY30205A1 (es) Derivados de cromano, sales del mismo farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones
SE0302382D0 (sv) New salts II
RU2015106931A (ru) Лекарственное средство от гастроэзофагеальной рефлюксной болезни
CL2008003871A1 (es) Metodo para preparar 5-(1h-pirrol-1-il)-2-mercaptobenzimidazol.
WO2008084067A3 (en) Pharmaceutically active dihydrobenzofurane-substituted benzimidazole derivatives
TH90875B (th) อนุพันธ์เบนซิมิดาโซลที่ถูกแทนที่ด้วยโครเมน
WO2008017466A8 (en) Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties